Arecor Therapeutics (AREC) RNS Announcements

Add to Alert list
Date Time Source Announcement
02 Dec 2024 07:00 AM
RNS
Grant of Options and PDMR Dealing
18 Nov 2024 07:00 AM
RNS
Arecor Appoints Interim Chief Financial Officer
27 Sep 2024 07:00 AM
RNS
Arecor to present on Investor Meet Company
26 Sep 2024 07:00 AM
RNS
Interim Results for six months ended 30 June 2024
19 Sep 2024 03:17 PM
RNS
Notice of Results
11 Sep 2024 07:00 AM
RNS
Arecor presents positive AT278 data at EASD
03 Sep 2024 07:00 AM
RNS
Arecor announces AT278 presentation at EASD 2024
22 Aug 2024 04:34 PM
RNS
Holding(s) in Company
20 Aug 2024 01:44 PM
RNS
Holding(s) in Company
12 Aug 2024 03:02 PM
RNS
Holding(s) in Company
08 Aug 2024 02:48 PM
RNS
Result of General Meeting and Total Voting Rights
23 Jul 2024 04:26 PM
RNS
Posting of Circular and General Meeting
23 Jul 2024 07:00 AM
RNS
Result of WRAP Retail Offer
19 Jul 2024 06:22 PM
RNS
Result of Placing and Subscription
19 Jul 2024 01:17 PM
RNS
WRAP Retail Offer to raise up to £1 million
19 Jul 2024 01:10 PM
RNS
Proposed Placing and Subscription
28 Jun 2024 02:35 PM
RNS
Result of AGM
10 Jun 2024 07:00 AM
RNS
Trading and Funding Update
31 May 2024 04:05 PM
RNS
Posting of 2023 Annual Report and Notice of AGM
23 May 2024 07:00 AM
RNS
Grant of Options and PDMR Dealing
21 May 2024 07:00 AM
RNS
Arecor to host company and KOL webinar today
20 May 2024 07:00 AM
RNS
Positive headline results for AT278 clinical trial
16 May 2024 07:00 AM
RNS
Final results for 2023
14 May 2024 10:17 AM
RNS
Notice of Results
09 May 2024 07:00 AM
RNS
Arecor and Medtronic Diabetes collaboration
03 May 2024 04:44 PM
RNS
Publication of Full Year Financial Results delayed
29 Apr 2024 07:00 AM
RNS
Notice of results
23 Apr 2024 07:00 AM
RNS
BOARD CHANGE
12 Mar 2024 08:58 AM
RNS
Arecor and TRx Biosciences research collaboration
12 Mar 2024 07:00 AM
RNS
Arecor and TRx Biosciences research collaboration
29 Feb 2024 07:00 AM
RNS
Arecor announces launch of Ogluo® in Netherlands
01 Feb 2024 07:00 AM
RNS
Year End Trading Update
23 Jan 2024 04:58 PM
RNS
Arecor announces update on INBRX-101
18 Jan 2024 07:00 AM
RNS
Arecor granted key European patent
08 Jan 2024 07:00 AM
RNS
Expansion of specialty hospital collaboration
03 Jan 2024 07:00 AM
RNS
Appointment of SVP for Tetris Pharma Ltd
04 Dec 2023 07:00 AM
RNS
Agreement with global medical products company
29 Nov 2023 07:00 AM
RNS
Arecor Continues Collaboration with Lilly
17 Nov 2023 07:00 AM
RNS
Product with Arestat technology launched in Europe
02 Nov 2023 07:00 AM
RNS
Inhibrx milestone triggers payment to Arecor
01 Nov 2023 03:31 PM
RNS
Exercise of rollover options & Total Voting Rights
02 Oct 2023 07:00 AM
RNS
Progress of Phase I clinical study of AT278
15 Sep 2023 07:00 AM
RNS
Arecor on Investor Meet Company Platform
14 Sep 2023 07:00 AM
RNS
Interim Results for six months ended 30 June 2023
07 Sep 2023 07:00 AM
RNS
Arecor: positive Hikma FDA pre-IND meeting
04 Sep 2023 07:00 AM
RNS
TETRIS PHARMA ANNOUNCES AGREEMENT WITH GOODLIFE
17 Aug 2023 07:00 AM
RNS
Collaboration With Top 10 Global Pharma
10 Aug 2023 07:00 AM
RNS
Notice of Interim Results
20 Jul 2023 07:00 AM
RNS
Arecor Business Update
05 Jul 2023 07:00 AM
RNS
Additional Agreement with Leading Biopharma
UK 100

Latest directors dealings